Cited 2 times in 
Cited 0 times in 
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC Reply
https://orcid.org/0000-0002-5562-270XItems in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.